Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 27.59 is 135% above its 5-year average of 11.75, near the high end of its 5-year range (7.39–27.59).
As of the fiscal period ended Tuesday, June 30, 2026. 55.69% above its 12-month average of 17.72.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 27.59.
CURRENT RATIO
27.59
CURRENT RATIO AVG TTM
17.72
CURRENT RATIO AVG 3Y
10.24
CURRENT RATIO AVG 5Y
11.75
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+55.69%
CURRENT VS 3Y AVG
+169.33%
CURRENT VS 5Y AVG
+134.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+633.69%
vs the sector median at left
Shattuck Labs, Inc.
Market Cap
$529.58M
Current Ratio
27.59
TTM Avg
17.72
3Y Avg
10.24
5Y Avg
11.75
Market Cap
$533.04M
Current Ratio
33.56
TTM Avg
31.41
3Y Avg
17.80
5Y Avg
16.41
Market Cap
$524.43M
Current Ratio
25.13
TTM Avg
6.17
3Y Avg
7.34
5Y Avg
19.91
Market Cap
$516.76M
Current Ratio
3.46
TTM Avg
4.63
3Y Avg
6.00
5Y Avg
6.13
Market Cap
$548.51M
Current Ratio
1.92
TTM Avg
2.96
3Y Avg
5.58
5Y Avg
6.23
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | $529.58M | 27.59 | 17.72 | 10.24 | 11.75 |
| Nuvectis Pharma, Inc. (NVCT)vs › | $531.52M | 1.68 | 2.23 | 2.63 | 2.59 |
| Delcath Systems, Inc. (DCTH)vs › | $531.98M | 9.83 | 11.46 | 6.57 | 5.79 |
| Monopar Therapeutics Inc. (MNPR)vs › | $533.04M | 33.56 | 31.41 | 17.80 | 16.41 |
| Immix Biopharma, Inc. (IMMX)vs › | $524.43M | 25.13 | 6.17 | 7.34 | 19.91 |
| ProKidney Corp. (PROK)vs › | $538.01M | 8.36 | 10.03 | 20.35 | 14.11 |
| Altimmune, Inc. (ALT)vs › | $519.25M | 26.78 | 15.83 | 15.06 | 15.09 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $516.76M | 3.46 | 4.63 | 6.00 | 6.13 |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $548.51M | 1.92 | 2.96 | 5.58 | 6.23 |
| 908 Devices Inc. (MASS)vs › | $505.87M | 2.67 | 4.17 | 6.82 | 10.02 |
Current Ratio
27.59
Quick Ratio
27.59
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 27.59 |
| 2026-03-31 | 22.06 |
| 2025-12-31 | 11.70 |
| 2025-09-30 | 17.00 |
| 2025-06-30 | 10.25 |
| 2025-03-31 | 9.08 |
| 2024-12-31 | 8.88 |
| 2024-09-30 | 7.96 |
| 2024-06-30 | 7.62 |
| 2024-03-31 | 9.15 |
| 2023-12-31 | 12.51 |
| 2023-09-30 | 8.04 |
| 2023-06-30 | 10.50 |
| 2023-03-31 | 9.86 |
| 2022-12-31 | 7.39 |
| 2022-09-30 | 10.53 |
| 2022-06-30 | 9.46 |
| 2022-03-31 | 15.17 |
| 2021-12-31 | 11.72 |
| 2021-09-30 | 15.21 |
| 2021-06-30 | 20.90 |
| 2021-03-31 | 18.49 |
| 2020-12-31 | 20.53 |
| 2020-09-30 | 8.63 |
| 2020-06-30 | 10.54 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.12 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
